104196-14-7

Basic information

• Product Name: 3,3'-neotrehalosadiamine
• Synonyms: 3,3'-neotrehalosadiamine;3-Amino-3-deoxy-β-D-glucopyranosyl 3-amino-3-deoxy-α-D-glucopyranoside;BMY-28251;Bu-2797;Neotrehalosadiamine
• CAS NO: 104196-14-7
• Molecular Formula: C₁₂H₂₄N₂O₉
• Molecular Weight: 340.327
• Mol File: 104196-14-7.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3,3'-neotrehalosadiamine(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3'-neotrehalosadiamine(104196-14-7)
• EPA Substance Registry System: 3,3'-neotrehalosadiamine(104196-14-7)

Safety Data

• Hazardous Substances Data: 104196-14-7(Hazardous Substances Data)

Usage

General Description

3,3’-neotrehalosadiamine is a chemical compound that belongs to the class of amines. It is a derivative of neotrehalose, which is a disaccharide found in some bacteria and fungi. The compound consists of two amino groups attached to a central hexose ring, and it is used as a building block for the synthesis of more complex molecules. 3,3’-neotrehalosadiamine has potential applications in the pharmaceutical and biotechnology industries, particularly in the development of new drugs and biocatalysts. Its unique structure and properties make it a valuable tool for the creation of novel chemical compounds with a range of potential applications.

Upstream product

• 185114-94-7 1,2,4,6-Tetra-O-acetyl-3-azido-3-deoxy-α/β-gluco-hexopyranose 
• 1417719-76-6 2,4,6-tri-O-acetyl-3-azido-3-deoxy-a-D-glucopyranosyl-(1→1')-2',4',6'-tri-O-acetyl-3'-azido-3'-deoxy-b-D-glucopyranoside 
• 1417719-77-7 3-azido-3-deoxy-α-D-glucopyranosyl-(1→1')-3-azido-30-deoxy-b-D-glucopyranoside 

Relevant articles and documents

Diverse Synthesis of Natural Trehalosamines and Synthetic 1,1′-Disaccharide Aminoglycosides

A general strategy for the diverse synthesis of ten disaccharide aminoglycosides, including natural 2-trehalosamine (1), 3-trehalosamine (2), 4-trehalosamine (3), and neotrehalosyl 3,3′-diamine (8) and synthetic aminoglycosides 4–7, 9, and 10, has been developed. The aminoglycoside compounds feature different anomeric configurations and numbers of amino groups. The key step for the synthesis was the glycosylation coupling of a stereodirecting donor with a configuration-stable TMS glycoside acceptor. Either the donor or acceptor could be substituted with an azido group. The aminoglycosides prepared in the present study were characterized by 1D and 2D NMR spectroscopy.